AiCuris Anti-infective Cures GmbH
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From AiCuris Anti-infective Cures GmbH
Repurposed drugs, new compounds and neutralizing antibodies are among the targets of a new collaborative venture supported by Europe’s Innovative Medicines Initiative.
Heads of vaccines development at partners GSK and Sanofi:“This is not a sprint, it’s a marathon.”
Company specializing in trading upfront cash for downstream earnings makes its public debut with largest IPO of 2020, and the second largest ever in biopharma.
Skyhawk continues its recent spate of deal-making, using its SkyStar platform in a deal with Genentech, which also is looking into neurology with Convelo. AbbVie buys STING specialist Mavupharma, while Recordati pays Novartis $390m for Cushing’s products.
- Drug Discovery Tools